with RMD, and the American College of Rheumatology (ACR) recognizes the imperative for guidance in reproductive health issues for these patients. RESULTS/RECOMMENDATIONS The detailed tables of recommendations appear in Supplementary Appendix 7 (available on the Arthritis & Rheumatology web site at http://onlin elibr ary.wiley.com/doi/10.1002/art.41191/ abstract 1 Positive aPL test Negative aPL test Non-SLE RMD SLE Low disease activity SLE Mod-high disease activity AVOID combined estrogenprogestin contraceptives LEGEND Avoid DMPA in patients at risk for osteoporosis Detailed definitions of aPL and antiphospholipid syndrome (APS) are presented in Supplementary Appendix 8 (available on the Arthritis & Rheumatology web site at http://onlin elibr ary.wiley. com/doi/10.1002/art.41191/abstract Patients with lower-titer aCL and/or anti-Î² 2 GPI (or noncriteria aPL) who do not meet laboratory classification criteria may still have some degree of risk that is difficult to quantify.